针对性阿尔法疗法 (TAT) 使用单域抗体 (纳米体)
Kate Hurley1, Meiyun Cao1, Haiming Huang2
1Radiobiology and Health, Canadian Nuclear Laboratories, Chalk River, ON K0J 1J0, Canada.
Cancers
|July 14, 2023
概括
纳米体为向阿尔法疗法 (TαT) 提供了一个有希望的解决方案,通过减少副作用来改善癌症治疗. 这些小型抗体碎片增强瘤向性,并最大限度地降低对健康组织的毒性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 放射性药物 放射性药物 放射性药物
背景情况:
- 向性阿尔法疗法 (TαT) 使用阿尔法发射粒子治疗癌症,旨在最大限度地减少对健康组织的损伤.
- 传统的TαT通常使用全长抗体,由于它们的血液半衰期长,并在器官中积累,可以引起显著的非向毒性.
- 单域抗体 (纳米体) 是小的,自然存在的抗原结合片段,有可能克服较大的抗体的局限性.
研究的目的:
- 审查利用纳米体作为向阿尔法疗法 (TαT) 的向载体的最新进展.
- 突出纳米体在TαT中比全长抗体具有优势,重点关注药理动力学和毒性.
- 探索纳米技术在提高癌症放射性免疫疗法的疗效和安全方面的潜力.
主要方法:
- 关于纳米体开发和在向阿尔法疗法中的应用现有文献的综述.
- 与全长抗体相比,纳米体的药物动力学特性分析.
- 对基于纳米体的TαT策略进行瘤向和非向毒性降低的评估.
主要成果:
- 纳米体具有较短的血液半衰期,增强的瘤吸收,以及高的结合亲和力和特异性.
- 它们的药物动力学概况非常适合短寿命的α发射放射性核素.
- 纳米体技术显示出有可能显著减少与传统基于抗体的TαT.相关的骨髓和器官毒性.
结论:
- 与全长抗体相比,纳米体代表了针对性阿尔法疗法的优越向载体.
- 纳米体的独特特性提供了一个可行的策略,以提高TαT的治疗指数.
- 基于纳米体的TαT的进一步开发对更有效,更安全的癌症治疗具有重大前景.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K